| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.5 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.5 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |